Simultaneous combination of chemotherapy using protracted infusion of low-dose cisplatin and 5-fluorouracil with radiotherapy. Relationship between the size of the irradiation field and hemotoxicity

Anticancer Research

Volumn 23, Issue 2 C, 2003, Pages 1709-1711

  Itoh, Yoshiyuki ^a   Huwa, Nobukazu ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

5 fluorouracil; Chemoradiotherapy; Cisplatin; Esophageal cancer; Hemotoxicity; Lung cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER PATIENT; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; ESOPHAGUS CANCER; HUMAN; IRRADIATION; LEUKOCYTE COUNT; LOW DRUG DOSE; LUNG CANCER; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HEMATOLOGIC DISEASES; HUMANS; INFUSIONS, INTRAVENOUS; LEUKOCYTE COUNT; LUNG NEOPLASMS; MIDDLE AGED; PLATELET COUNT; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 0038539253     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Itoh Y, Fuwa N, Mastumoto A, Asano A and Sasaoka M: Concurrent chemoradiotherapy using protracted infusion of low-dose CDDP and 5-FU and radiotherapy for esophageal cancer. Nippon Acta Radiol 59: 395-401, 1999.
2. Itoh Y, Fuwa N, Mastumoto A, Asano A and Morita K: Continuous infusion low-dose CDDP/5-FU plus radiation in operable or recurrent non-small-cell lung cancer: Preliminary experience. Am J Clin Oncol 25(3): 230-234, 2002.
3. Itoh Y, Fuwa N, Kato E, Kamata M and Morita K: Protracted continuous infusion of low-dose cisplatin and 5-fluorouracil with concomitant radiation therapy for head and neck cancer. Jpn J Clin Radiol 42: 1701-1703, 1997.
4. Tobinai K, Hohno A, Shjimada Y, Watanabe T, Tamura T, Takeyama K, Narabayashi M, Fukutomi T, Kondo H, Shimoyama M and Suemasu K: Toxicity grading criteria of the Japan Clinical Oncology Group. Jpn J Clin Oncol 23: 259-257, 1993.
5. John MJ, Flam MS, Mowry PA, Podolsky WJ, Xavier AM, Wittlinger PS and Padmanabhan A: Radiotherapy alone and chemoradiation for non-metastatic esophageal carcinoma. Cancer 63: 239-2403, 1989.
6. Coia LR, Engsrom PF, Paul AR, Stafford PM and Hanks GE: Long-term results of infusion 5-FU, mitomy-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phy 20: 29-36, 1991.
7. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF and Green MR: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. New Engl J Med 323: 940-945, 1990.
8. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, Dar R and Cox JD: RTOG 88-08 and ECOG 4588: Preliminary results of a phase III trial in regionally advanced unresectable non-small-cell lung cancer. J Natl Cancer Inst 87: 198-205, 1995.
9. Araujo CM, Souhami L, Gil RA, Carvalho R, Garcia JA, Froimtchuk MJ, Pinto LH and Canary PC: A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67: 2258-2261, 1991.
10. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius, Cooper J, Byhardt R, Davis L and Emami B: Combined chemotherapy and radiotherapy compared with radiation alone in patients with cancer of the esophagus. New Engl J Med 326: 1593-1598, 1992.
11. Smith TJ, Ryan LM and Douglass HO Jr: Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: as study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42: 269-276, 1998.
12. Hsu CH, Yen KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT and Cheng AL: Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil. Anticancer Res 19: 4463-4468, 1999.